Mr Appelbee is a senior pharmaceutical industry executive with 29 years’ international experience in both large and small corporations. His M&A track record includes the successful acquisition (on behalf of Sinclair plc) of Ashbourne Pharmaceuticals Ltd, of which he was recently Chairman. |
 |
Previously, as CEO of AiM-listed Maelor plc, he gained a strong reputation for fundraising in difficult market conditions,
and was recognised by the London Stock Exchange for his communication skills. Prior to this Stephen spent 9 years
in the US biotechnology sector, latterly as Senior Director of ALZA’s International Business Unit. |
|
